Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Clinical trial NCT00705016 · COMPLETED
Trial details
- NCT number
- NCT00705016
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-09-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.